Daewon Pharmaceutical Co., Ltd.

Symbol: 003220.KS

KSC

15170

KRW

Market price today

  • 13.1340

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 321.54B

    MRK Cap

  • 0.02%

    DIV Yield

Daewon Pharmaceutical Co., Ltd. (003220-KS) Stock Split, History Data

Working capital analysis

In terms of working capital, Daewon Pharmaceutical Co., Ltd. maintains a healthy position. The total current assets of the company are valued at $209293035076. This represents a growth rate of 0.969% compared to the previous year. Breaking down the current assets, the cash and investments are worth $29982402781, exhibiting a growth rate of 11.170% year-on-year. The receivables, another significant portion of the current assets, are valued at $73399655006. The year-on-year growth rate for receivables is 6.090%. The inventory, which forms a critical part of the assets, is valued at $105077999645. This represents a healthy year-on-year growth of 14.406% On the liabilities side, the company's current liabilities total $182690483039. This reflects a growth rate of 42.564% over the previous year, indicating the company's financial obligations are well under control.

202320222021202020192018
Cash and investments
29982.40
26969.83
41697.12
10439.09
13003.91
14887.43
Receavebles
73399.66
69186.17
56516.72
43484.94
51006.71
45642.68
Inventory
105078.00
91846.94
69690.50
63797.60
52158.64
44303.71
Other
785.27
754.92
650.33
526.68
414.95
0.00
Total Current Assets
209293.04
207283.82
180377.17
117276.45
121547.98
106724.04
Acc Payable
20909.85
19582.93
17221.94
10686.62
8935.58
6864.01
Short Term Debt
110577.21
63396.23
51728.03
22448.28
20848.93
19000.00
Other Current Liab
39573.59
40456.85
0.00
0.00
0.00
23616.83
Current Liabilities
182690.48
128146.38
102076.35
56017.09
61740.43
57694.15

Capital Structure

When examining the capital structure of Daewon Pharmaceutical Co., Ltd., it is clear that the company manages a robust portfolio. These earnings represent the profits that Daewon Pharmaceutical Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$NaN

Total liabilities

$NaN

Long term debt

$NaN

Cash and eqv

$NaN

Goodwill

$NaN

Retained earnings

$NaN

Common stock

$NaN

Enterprise Value

$1.30

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is 1368.293.

What is company revenue per share?

The company revenue per share is 0.061.

What are firm earnings per share?

The firm earnings per share is 0.928.

What is Daewon Pharmaceutical Co., Ltd. (003220.KS) ROIC (return on capital)?

Daewon Pharmaceutical Co., Ltd. (003220.KS) ROIC (return on capital) is 0.099.

What is dividend per share figure?

The dividend per share is 300.000

What is enterprise plowback ratio?

Daewon Pharmaceutical Co., Ltd. (003220.KS) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 1.304

What is company debt to equity ratio?

The debt to equity ratio is 0.545

What are debt ratio numbers?

The debt ratio is 0.286

What is company price to sales ratio?

The price to sales ratio is 0.596